Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
87.00
+1.29 (1.51%)
Jun 11, 2026, 12:42 PM EDT - Market open
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Rhythm Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $138.2. The average 1-year stock price forecast is 58.85% higher than the current stock price, while the lowest is $105 (+20.69%) and the highest is $159 (+82.76%).
Price Target: $138.2 (+58.85%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 20, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $143 | Buy | Reiterates | $143 | +64.37% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $105 | Buy | Reiterates | $105 | +20.69% | May 11, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $131 → $133 | Buy | Maintains | $131 → $133 | +52.87% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $140 → $143 | Buy | Maintains | $140 → $143 | +64.37% | May 7, 2026 |
Financial Forecast
Revenue This Year
298.09M
from 189.76M
Increased by 57.09%
Revenue Next Year
540.99M
from 298.09M
Increased by 81.49%
EPS This Year
-3.29
from -3.11
EPS Next Year
-0.79
from -3.29
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 321.0M | ||
| Avg | 298.1M | ||
| Low | 273.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 69.2% | ||
| Avg | 57.1% | ||
| Low | 44.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -3.29 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |